BioCentury
ARTICLE | Company News

Ambryx, Harvard University, Johns Hopkins University, Rockefeller University deal

November 1, 1999 8:00 AM UTC

Ambryx entered into three separate agreements focused on cancer. The company received an exclusive option to license Harvard's DNA sequences and related chemosensory receptor proteins and received an exclusive license from Johns Hopkins to an olfactory receptor library for ligand identification. With Rockefeller, Ambryx entered into an exclusive license and research agreement to discover G protein-coupled receptor molecules involved in chemosensation. ...